• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍中的快感缺失、快感亢进和负性强化。

Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.

机构信息

National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD, USA.

National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.

出版信息

Curr Top Behav Neurosci. 2022;58:147-165. doi: 10.1007/7854_2021_288.

DOI:10.1007/7854_2021_288
PMID:35112332
Abstract

Drug addiction has been defined as a chronically relapsing disorder that is characterized by a compulsion to seek and take a drug or stimulus, the loss of control in limiting intake, and the emergence of a negative emotional state when access to the drug or stimulus is prevented, a component of which is anhedonia. The present review explores a heuristic framework for understanding the role of anhedonia in addiction, in which anhedonia is a key component of hyperkatifeia (conceptualized as the potentiated intensity of negative emotional/motivational symptoms during drug withdrawal) and negative reinforcement in addiction. The neural substrates that mediate such anhedonia and crosstalk between elements of hyperkatifeia that contribute to anhedonia are then explored, including crosstalk between physical pain and emotional pain systems. The present review explores current knowledge of neurochemical neurocircuitry changes that are associated with conditioned hyperkatifeia/anhedonia. The overall hypothesis is that the shift in motivation toward negative reinforcement in addiction reflects the allostatic misregulation of hedonic tone, such that drug taking makes anhedonia worse during the process of seeking temporary relief by compulsive drug taking, thereby perpetuating the addiction cycle and hedonic comorbidities that are associated with addiction.

摘要

药物成瘾已被定义为一种慢性复发性疾病,其特征是强迫寻求和使用药物或刺激物,无法控制摄入,并且在阻止接触药物或刺激物时会出现负面情绪状态,其中一个组成部分是快感缺失。本综述探讨了一种理解快感缺失在成瘾中的作用的启发式框架,其中快感缺失是 hyperkatifeia(在药物戒断期间,将负面情绪/动机症状的强度增强)和成瘾中的负强化的关键组成部分。然后探讨了介导这种快感缺失的神经基质以及导致快感缺失的 hyperkatifeia 元素之间的串扰,包括身体疼痛和情绪疼痛系统之间的串扰。本综述探讨了与条件性 hyperkatifeia/快感缺失相关的神经化学神经回路变化的现有知识。总体假设是,成瘾中对负强化的动机转变反映了愉悦音调的适应不良调节,因此,在通过强迫性药物滥用寻求暂时缓解的过程中,药物使用会使快感缺失恶化,从而使成瘾循环和与成瘾相关的愉悦共病持续存在。

相似文献

1
Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.物质使用障碍中的快感缺失、快感亢进和负性强化。
Curr Top Behav Neurosci. 2022;58:147-165. doi: 10.1007/7854_2021_288.
2
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.药物成瘾:Hyperkatifeia/负性强化作为药物开发的框架。
Pharmacol Rev. 2021 Jan;73(1):163-201. doi: 10.1124/pharmrev.120.000083.
3
Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement.阿片类药物成瘾的神经生物学:对抗过程、超快感和负强化。
Biol Psychiatry. 2020 Jan 1;87(1):44-53. doi: 10.1016/j.biopsych.2019.05.023. Epub 2019 Jun 12.
4
Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.抗奖赏、强迫性与成瘾:阿西娜·马尔库博士对成瘾中动机失调的开创性贡献。
Psychopharmacology (Berl). 2017 May;234(9-10):1315-1332. doi: 10.1007/s00213-016-4484-6. Epub 2017 Jan 3.
5
Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder.酒精成瘾的理论框架与机制层面:酒精成瘾作为一种奖赏缺乏/压力过剩障碍
Curr Top Behav Neurosci. 2023 Jul 9. doi: 10.1007/7854_2023_424.
6
Neurobiological substrates for the dark side of compulsivity in addiction.成瘾中强迫性阴暗面的神经生物学基础。
Neuropharmacology. 2009;56 Suppl 1(Suppl 1):18-31. doi: 10.1016/j.neuropharm.2008.07.043. Epub 2008 Aug 7.
7
Addiction as a stress surfeit disorder.成瘾作为一种应激过度障碍。
Neuropharmacology. 2014 Jan;76 Pt B(0 0):370-82. doi: 10.1016/j.neuropharm.2013.05.024. Epub 2013 Jun 6.
8
Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.成瘾中神经回路的动力学:奖赏、反奖赏与情绪记忆。
Pharmacopsychiatry. 2009 May;42 Suppl 1(Suppl 1):S32-41. doi: 10.1055/s-0029-1216356. Epub 2009 May 11.
9
Neurocircuitry of alcohol addiction: synthesis from animal models.酒精成瘾的神经回路:来自动物模型的综合研究
Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3.
10
Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.酒精成瘾的理论框架与机制层面:酒精成瘾作为一种奖赏缺乏障碍。
Curr Top Behav Neurosci. 2013;13:3-30. doi: 10.1007/7854_2011_129.

引用本文的文献

1
A Preclinical Alcohol Biobank: Samples from Behaviorally Characterized HS Rats for AUD Research.一个临床前酒精生物样本库:来自对酒精使用障碍(AUD)研究进行行为特征化的HS大鼠的样本。
eNeuro. 2025 Sep 12;12(9). doi: 10.1523/ENEURO.0207-25.2025. Print 2025 Sep.
2
A Preclinical Alcohol BioBank: Samples from Behaviorally Characterized HS Rats for AUD Research.一个临床前酒精生物样本库:来自行为特征明确的HS大鼠的样本用于酒精使用障碍研究。
bioRxiv. 2025 May 7:2025.04.30.651600. doi: 10.1101/2025.04.30.651600.
3
Plasma metabolic profiles in alcohol use disorder: diagnostic role of arginine and emotional implications of N6-acetyl-lysine and succinic acid.

本文引用的文献

1
κ-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats.κ-阿片受体拮抗作用可逆转海洛因戒断诱导的雄性和雌性大鼠痛觉过敏。
Neurobiol Stress. 2021 Apr 14;14:100325. doi: 10.1016/j.ynstr.2021.100325. eCollection 2021 May.
2
Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction.与戒断和负强化相关的线索:被忽视但关键的动机元素,推动阿片类药物成瘾。
Sci Adv. 2021 Apr 7;7(15). doi: 10.1126/sciadv.abf0364. Print 2021 Apr.
3
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
酒精使用障碍中的血浆代谢谱:精氨酸的诊断作用以及N6-乙酰赖氨酸和琥珀酸的情感意义
BMC Psychiatry. 2025 Jun 2;25(1):563. doi: 10.1186/s12888-025-07014-9.
4
Subgroups of anxiety and depression trajectories during early abstinence in alcohol use disorder.酒精使用障碍早期戒酒期间焦虑和抑郁轨迹的亚组。
Alcohol Clin Exp Res (Hoboken). 2025 May;49(5):1086-1096. doi: 10.1111/acer.70032. Epub 2025 May 8.
5
Prenatal methadone exposure produces functional and molecular alterations in the basolateral amygdala and decreased voluntary ethanol intake in female, but not male offspring.产前接触美沙酮会导致雌性后代基底外侧杏仁核出现功能和分子改变,并减少其自愿乙醇摄入量,但对雄性后代无此影响。
Front Behav Neurosci. 2025 Apr 15;19:1570951. doi: 10.3389/fnbeh.2025.1570951. eCollection 2025.
6
Pharmacological Perspective on the Neurobiology of PI3K-Akt-mTOR Signalling in Opioid Dependence.阿片类药物依赖中PI3K-Akt-mTOR信号通路神经生物学的药理学视角
CNS Neurol Disord Drug Targets. 2025;24(9):652-668. doi: 10.2174/0118715273377530250408212447.
7
Expanding the scope of the withdrawal syndrome: Anhedonia as a core nicotine withdrawal symptom.扩大戒断综合征的范围:快感缺失作为尼古丁戒断的核心症状。
J Psychopathol Clin Sci. 2025 Jul;134(5):540-553. doi: 10.1037/abn0000981. Epub 2025 Apr 7.
8
Addressing Altered Anticipation as a Transdiagnostic Target Through Computational Psychiatry.通过计算精神病学将改变的预期作为跨诊断靶点来解决。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Mar 7. doi: 10.1016/j.bpsc.2025.02.014.
9
Opioidergic tuning of social attachment: reciprocal relationship between social deprivation and opioid abuse.社会依恋的阿片能调节:社会剥夺与阿片类药物滥用之间的相互关系。
Front Neuroanat. 2025 Jan 23;18:1521016. doi: 10.3389/fnana.2024.1521016. eCollection 2024.
10
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits.丁丙诺啡的药效学:理解丁丙诺啡临床益处的桥梁。
Drugs. 2025 Feb;85(2):215-230. doi: 10.1007/s40265-024-02128-y. Epub 2025 Jan 28.
药物成瘾:Hyperkatifeia/负性强化作为药物开发的框架。
Pharmacol Rev. 2021 Jan;73(1):163-201. doi: 10.1124/pharmrev.120.000083.
4
Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19.成瘾作为一种应对反应:极度痛苦、绝望死亡与新冠疫情
Am J Psychiatry. 2020 Nov 1;177(11):1031-1037. doi: 10.1176/appi.ajp.2020.20091375.
5
Converging Structural and Functional Evidence for a Rat Salience Network.汇聚的大鼠突显网络的结构和功能证据。
Biol Psychiatry. 2020 Dec 1;88(11):867-878. doi: 10.1016/j.biopsych.2020.06.023. Epub 2020 Jul 2.
6
Depletion of the Microbiome Alters the Recruitment of Neuronal Ensembles of Oxycodone Intoxication and Withdrawal.肠道微生物组耗竭改变了羟考酮中毒和戒断时神经元集合体的募集。
eNeuro. 2020 May 21;7(3). doi: 10.1523/ENEURO.0312-19.2020. Print 2020 May/Jun.
7
Addictions NeuroImaging Assessment (ANIA): Towards an integrative framework for alcohol use disorder.成瘾神经影像学评估(ANIA):迈向酒精使用障碍的综合框架
Neurosci Biobehav Rev. 2020 Jun;113:492-506. doi: 10.1016/j.neubiorev.2020.04.004. Epub 2020 Apr 13.
8
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.一项应用“快速失败”方法评估 κ 阿片受体拮抗剂作为快感缺失治疗药物的机制验证随机试验。
Nat Med. 2020 May;26(5):760-768. doi: 10.1038/s41591-020-0806-7. Epub 2020 Mar 30.
9
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.阿片类药物戒断症状是慢性阿片类药物使用和阿片类药物使用障碍的后果:目前的认识和管理方法。
J Clin Pharm Ther. 2020 Oct;45(5):892-903. doi: 10.1111/jcpt.13114. Epub 2020 Jan 27.
10
Life Expectancy and Mortality Rates in the United States, 1959-2017.美国 1959-2017 年的预期寿命和死亡率。
JAMA. 2019 Nov 26;322(20):1996-2016. doi: 10.1001/jama.2019.16932.